Medicine and Dentistry
Cardiovascular System
66%
Cardiovascular Disease
66%
Sodium Glucose Cotransporter 2 Inhibitor
66%
Glucagon-Like Peptide-1 Agonist
50%
Drug
33%
Chemotherapeutic Agent
33%
Pioglitazone
33%
Therapeutic Procedure
33%
Maturity Onset Diabetes of the Young
16%
Insulin Resistance
16%
Obesity
16%
Glucose
16%
Fatty Acid
16%
Caloric Intake
16%
Caloric Restriction
16%
Cardiovascular Effect
16%
Glucosuria
16%
Mechanism of Action
16%
Nursing and Health Professions
Body Weight Loss
83%
Cardiovascular Disease
66%
Sodium Glucose Cotransporter 2 Inhibitor
66%
Glucagon Like Peptide 1 Receptor Agonist
50%
Diabetes Mellitus
33%
Drug
33%
Pioglitazone
33%
Prevention
16%
Insulin Resistance
16%
Obesity
16%
Drug Therapy
16%
Glucose
16%
Caloric Intake
16%
Control
16%
Caloric Restriction
16%
Glucosuria
16%
Psychology
Glucose
100%
Weight Loss
83%
Cotransporter
83%
Diabetes
50%
Treatment
33%
Obesity
16%
Insulin Resistance
16%
Neuroscience
Sodium Glucose Cotransporter 2
66%
Glucagon-Like Peptide-1 Receptor Agonist
50%
Diabetes
33%
Pioglitazone
33%
Brain Areas
33%
Free Fatty Acids
33%
Glucose
16%
Diabetes Mellitus
16%
Sodium Glucose Cotransporter
16%
Biochemistry, Genetics and Molecular Biology
Weight
83%
Pioglitazone
33%
Glucose
16%
Calorie
16%
Insulin Resistance
16%
Cardiovascular Effect
16%
Reduction (Chemistry)
16%